Melinta Therapeutics Appoints Sunitha Lakshminarayanan As Chief Technology Officer
Sep 05, 2024•over 1 year ago
Position
Chief Technology Officer
Company
Melinta Therapeutics
ParsippanyBiopharmaTherapeuticsBiotechnologyDescription
Melinta Therapeutics has appointed Sunitha Lakshminarayanan as their new Chief Technology Officer. With a wealth of experience across small molecules, biologics, biosimilars, vaccines, and cell/gene therapy, she brings valuable expertise to the company.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months